首页> 外国专利> COMPOSITION COMPRISING A PRO364 OR PRO175 POLYPEPTIDE IN ADMIXTURE WITH A PHARMACEUTICALLY ACCEPTABLE CARRIER AND CARDIOVASCULAR, ENDOTHELIAL OR ANGIOGENIC AGENT, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND THEIR USE FOR PREPARING MEDICAMENTS

COMPOSITION COMPRISING A PRO364 OR PRO175 POLYPEPTIDE IN ADMIXTURE WITH A PHARMACEUTICALLY ACCEPTABLE CARRIER AND CARDIOVASCULAR, ENDOTHELIAL OR ANGIOGENIC AGENT, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND THEIR USE FOR PREPARING MEDICAMENTS

机译:包含PRO364或PRO175多肽的组合物,该组合物具有药学可接受的载体和心血管,血管内皮或血管生成剂,组成其的药物组合物及其在制备药物中的用途

摘要

Compositions and methods are disclosed for stimulating or inhibiting angiogenesis and/or cardiovascularization in mammals, including humans. Pharmaceutical compositions are based on polypeptides or antagonists thereto that have been identified for one or more of these uses. Disorders that can be diagnosed, prevented, or treated by the compositions herein include trauma such as wounds, various cancers, and disorders of the vessels including atherosclerosis and cardiac hypertrophy.
机译:公开了用于刺激或抑制包括人在内的哺乳动物的血管生成和/或心血管形成的组合物和方法。药物组合物基于已经针对一种或多种这些用途鉴定的多肽或其拮抗剂。可以通过本文的组合物诊断,预防或治疗的疾病包括创伤,例如伤口,各种癌症和血管疾病,包括动脉粥样硬化和心脏肥大。

著录项

  • 公开/公告号IL147442A

    专利类型

  • 公开/公告日2010-11-30

    原文格式PDF

  • 申请/专利权人 GENENTECH INC.;

    申请/专利号IL20020147442

  • 发明设计人

    申请日2002-01-02

  • 分类号G01N33/50;A61K38;A61K38/17;A61K39/395;A61K45;A61P1/04;A61P3/10;A61P7/02;A61P7/10;A61P9;A61P9/04;A61P9/10;A61P9/12;A61P9/14;A61P11;A61P13/12;A61P15;A61P17/02;A61P17/06;A61P19/10;A61P21;A61P25;A61P25/14;A61P25/16;A61P25/28;A61P27/02;A61P27/06;A61P29;A61P35;A61P41;A61P43;C07K14/47;C12N15/09;C12Q1/02;G01N33/15;G01N33/53;G01N33/566;G01N33/574;

  • 国家 IL

  • 入库时间 2022-08-21 18:06:27

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号